{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:12:50Z","timestamp":1788246770409,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13353-026-01061-y","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:36:47Z","timestamp":1776904607000},"page":"617-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular interplay of lncRNAs, miRNAs, and mRNAs axes in triple-negative breast cancer: implications for metastatic progression"],"prefix":"10.1007","volume":"67","author":[{"given":"Deepshikha","family":"Rathore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6886-0689","authenticated-orcid":false,"given":"Nishita","family":"Adnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandani","family":"Dharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6029-6515","authenticated-orcid":false,"given":"Heena V.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"8","key":"1061_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nm.4135","volume":"22","author":"C Adriaens","year":"2016","unstructured":"Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PWG, Radaelli E, Vermi W, Leucci E, Lapouge G, Beck B, van den Oord J, Nakagawa S, Hirose T, Sablina AA, Lambrechts D, Aerts S, Marine J-C (2016) p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med 22(8):861\u2013868. https:\/\/doi.org\/10.1038\/nm.4135","journal-title":"Nat Med"},{"issue":"1","key":"1061_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.270959.115","volume":"30","author":"G Arun","year":"2016","unstructured":"Arun G, Diermeier S, Akerman M, Chang K-C, Wilkinson JE, Hearn S, Kim Y, MacLeod AR, Krainer AR, Norton L, Brogi E, Egeblad M, Spector DL (2016) Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev 30(1):34\u201351. https:\/\/doi.org\/10.1101\/gad.270959.115","journal-title":"Genes Dev"},{"key":"1061_CR4","doi-asserted-by":"publisher","unstructured":"Be\u0148a\u010dka R, Szab\u00f3ov\u00e1 D, Gu\u013ea\u0161ov\u00e1 Z, Hertelyov\u00e1 Z, Rado\u0148ak J (2023) Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. Int J Mol Sci 24(22). https:\/\/doi.org\/10.3390\/ijms242216213","DOI":"10.3390\/ijms242216213"},{"issue":"1","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"8816102","DOI":"10.1155\/2024\/8816102","volume":"2024","author":"E Bustamante","year":"2024","unstructured":"Bustamante E, Casas F, Luque R, Piedra L, Barros-Sevillano S, Chambergo-Michilot D, Torres-Roman JS, Narvaez-Rojas A, Morante Z, Enriquez-Vera D, Desai A, Razuri C, De la Cruz-Ku G, Araujo J (2024) Brain Metastasis in Triple-Negative Breast Cancer. Breast J 2024(1):8816102. https:\/\/doi.org\/10.1155\/2024\/8816102","journal-title":"Breast J"},{"issue":"1","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2022","unstructured":"Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA (2022) Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Therapy 7(1):121. https:\/\/doi.org\/10.1038\/s41392-022-00975-3","journal-title":"Signal Transduct Target Therapy"},{"key":"1061_CR7","doi-asserted-by":"publisher","unstructured":"Chi Y, Wang D, Wang J, Yu W, Yang J (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells 8(9). https:\/\/doi.org\/10.3390\/cells8091015","DOI":"10.3390\/cells8091015"},{"issue":"1","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-024-02058-4","volume":"10","author":"M Dragonetti","year":"2024","unstructured":"Dragonetti M, Turco C, Benedetti A, Goeman F, Forcato M, Scalera S, Allegretti M, Esposito G, Fazi F, Blandino G, Donzelli S, Fontemaggi G (2024) The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell Death Discovery 10(1):276. https:\/\/doi.org\/10.1038\/s41420-024-02058-4","journal-title":"Cell Death Discovery"},{"issue":"2","key":"1061_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1541-7786.MCR-14-0251","volume":"13","author":"G Eades","year":"2015","unstructured":"Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q (2015) lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Research: MCR 13(2):330\u2013338. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0251","journal-title":"Mol Cancer Research: MCR"},{"key":"1061_CR10","unstructured":"Efficacy and Safety Study of TA(E)C-GP Versus A(E)C-T for the High Risk Triple-negative Breast Cancer Patients Predicted by the Messenger RNA (mRNA)-Long Non-coding RNA (lncRNA) Signature and Validation of the Signature\u2019s Efficacy (2015). https:\/\/clinicaltrials.gov\/study\/NCT02641847"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"113609","DOI":"10.1016\/j.biopha.2022.113609","volume":"154","author":"M Entezari","year":"2022","unstructured":"Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S (2022) LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomed Pharmacother 154:113609. https:\/\/doi.org\/10.1016\/j.biopha.2022.113609","journal-title":"Biomed Pharmacother"},{"issue":"null","key":"1061_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/BCTT.S114659","volume":"8","author":"B Fleisher","year":"2016","unstructured":"Fleisher B, Clarke C, Ait-Oudhia S (2016) Current advances in biomarkers for targeted therapy in triple-negative breast cancer. Breast Cancer: Targets Therapy 8(null):183\u2013197. https:\/\/doi.org\/10.2147\/BCTT.S114659","journal-title":"Breast Cancer: Targets Therapy"},{"key":"1061_CR13","doi-asserted-by":"publisher","unstructured":"Gao N, Li Y, Li J, Gao Z, Yang Z, Li Y, Liu H, Fan T (2020) Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.598817","DOI":"10.3389\/fonc.2020.598817"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"630300","DOI":"10.3389\/fonc.2021.630300","volume":"11","author":"W Guo","year":"2021","unstructured":"Guo W, Li J, Huang H, Fu F, Lin Y, Wang C (2021) LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of Tables 3 and PABPC4 in Triple Negative Breast Cancer. Front Oncol 11:630300. https:\/\/doi.org\/10.3389\/fonc.2021.630300","journal-title":"Front Oncol"},{"issue":"1","key":"1061_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-019-0995-1","volume":"18","author":"Y Guo","year":"2019","unstructured":"Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, Wang W, Wang G, Wang H, Yuan W, Ji Z, Sun Z (2019) Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer 18(1):39. https:\/\/doi.org\/10.1186\/s12943-019-0995-1","journal-title":"Mol Cancer"},{"issue":"3","key":"1061_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, Z\u00f6rnig M, MacLeod AR, Spector DL, Diederichs S (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73(3):1180\u20131189. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2850","journal-title":"Cancer Res"},{"issue":"4","key":"1061_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.apsb.2022.12.005","volume":"13","author":"S Han","year":"2023","unstructured":"Han S, Chen X, Huang L (2023) The tumor therapeutic potential of long non-coding RNA delivery and targeting. Acta Pharm Sinica B 13(4):1371\u20131382. https:\/\/doi.org\/10.1016\/j.apsb.2022.12.005","journal-title":"Acta Pharm Sinica B"},{"key":"1061_CR18","doi-asserted-by":"publisher","unstructured":"Huang Q-Y, Liu G-F, Qian X-L, Tang L-B, Huang Q-Y, Xiong L-X (2019) Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications. Cancers 11(11). https:\/\/doi.org\/10.3390\/cancers11111802","DOI":"10.3390\/cancers11111802"},{"issue":"11","key":"1061_CR19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M (2015) The emerging role of lncRNAs in cancer. Nat Med 21(11):1253\u20131261. https:\/\/doi.org\/10.1038\/nm.3981","journal-title":"Nat Med"},{"issue":"26","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"40418","DOI":"10.18632\/oncotarget.9622","volume":"7","author":"M Jadaliha","year":"2016","unstructured":"Jadaliha M, Zong X, Malakar P, Ray T, Singh DK, Freier SM, Jensen T, Prasanth SG, Karni R, Ray PS, Prasanth KV (2016) Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget 7(26):40418\u201340436. https:\/\/doi.org\/10.18632\/oncotarget.9622","journal-title":"Oncotarget"},{"issue":"6","key":"1061_CR21","doi-asserted-by":"publisher","first-page":"7383","DOI":"10.1007\/s13277-015-4605-6","volume":"37","author":"C Jin","year":"2016","unstructured":"Jin C, Lu Ybingchuan, Lin Q, Y., Ma L (2016) Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Tumor Biology 37(6):7383\u20137394. https:\/\/doi.org\/10.1007\/s13277-015-4605-6","journal-title":"Tumor Biology"},{"issue":"5","key":"1061_CR25","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41419-024-06675-w","volume":"15","author":"W-D Lin","year":"2024","unstructured":"Lin W-D, Chang C-H, Pan J-K, Lin F-C, Chen Y-C, Chen Y-J, Wang P-S, Hong W-Q, Chen S-Y, Lin C-H, Kuo Y-L, Chung W-P, Cheng H-C, Hsiao M, Yang C-N, Lu P-J (2024) A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer. Cell Death Dis 15(5):310. https:\/\/doi.org\/10.1038\/s41419-024-06675-w","journal-title":"Cell Death Dis"},{"key":"1061_CR26","doi-asserted-by":"publisher","unstructured":"Lin Y, Qi X, Chen J, Shen B (2022) Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis. Precision Clin Med 5(1). https:\/\/doi.org\/10.1093\/pcmedi\/pbac001","DOI":"10.1093\/pcmedi\/pbac001"},{"issue":"1","key":"1061_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12935-022-02536-8","volume":"22","author":"P Li","year":"2022","unstructured":"Li P, Zeng Y, Chen Y, Huang P, Chen X, Zheng W (2022) LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p\/NRP2 axis. Cancer Cell Int 22(1):116. https:\/\/doi.org\/10.1186\/s12935-022-02536-8","journal-title":"Cancer Cell Int"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"215781","DOI":"10.1016\/j.canlet.2022.215781","volume":"543","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang G, Yu T, He J, Liu J, Chai X, Zhao G, Yin D, Zhang C (2022) Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis. Cancer Lett 543:215781. https:\/\/doi.org\/10.1016\/j.canlet.2022.215781","journal-title":"Cancer Lett"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.omto.2021.11.005","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ding W, Yu W, Zhang Y, Ao X, Wang J (2021) Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol Therapy Oncolytics 23:458\u2013476. https:\/\/doi.org\/10.1016\/j.omto.2021.11.005","journal-title":"Mol Therapy Oncolytics"},{"issue":"1","key":"1061_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12935-020-01261-4","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Ma H-Y, Hu X-W, Qu Y-Y, Wen X, Zhang Y, Xu Q-Y (2020) LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53\/TNFAIP8 pathway. Cancer Cell Int 20(1):200. https:\/\/doi.org\/10.1186\/s12935-020-01261-4","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1061_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12935-024-03426-x","volume":"24","author":"F Long","year":"2024","unstructured":"Long F, Li X, Pan J, Ye H, Di C, Huang Y, Li J, Zhou X, Yi H, Huang Q, Si J (2024) The role of lncRNA NEAT1 in human cancer chemoresistance. Cancer Cell Int 24(1):236. https:\/\/doi.org\/10.1186\/s12935-024-03426-x","journal-title":"Cancer Cell Int"},{"issue":"11","key":"1061_CR31","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/carcin\/23.11.1885","volume":"23","author":"S Lottin","year":"2002","unstructured":"Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ (2002) Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 23(11):1885\u20131895. https:\/\/doi.org\/10.1093\/carcin\/23.11.1885","journal-title":"Carcinogenesis"},{"key":"1061_CR30","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Urrutia E, Bustamante Montes LP, de Guevara Cervantes D, P\u00e9rez-Plasencia C, Campos-Parra AD (2019) Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer. Front Oncol 9. https:\/\/doi.org\/10.3389\/fonc.2019.00669","DOI":"10.3389\/fonc.2019.00669"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2147\/OTT.S293685","volume":"14","author":"Y Lv","year":"2021","unstructured":"Lv Y, Ma X, Du Y, Feng J (2021) Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets. OncoTargets Therapy 14:589\u2013607. https:\/\/doi.org\/10.2147\/OTT.S293685","journal-title":"OncoTargets Therapy"},{"issue":"3","key":"1061_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bbrc.2018.04.119","volume":"500","author":"J Ma","year":"2018","unstructured":"Ma J, Yang Y, Huo D, Wang Z, Zhai X, Chen J, Sun H, An W, Jie J, Yang P (2018) LincRNA-RoR\/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1. Biochem Biophys Res Commun 500(3):614\u2013620. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.119","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1061_CR34","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1186\/s12885-020-07394-z","volume":"20","author":"T Ma","year":"2020","unstructured":"Ma T, Liu H, Liu Y, Liu T, Wang H, Qiao F, Song L, Zhang L (2020) USP6NL mediated by LINC00689\/miR-142-3p promotes the development of triple-negative breast cancer. BMC Cancer 20(1):998. https:\/\/doi.org\/10.1186\/s12885-020-07394-z","journal-title":"BMC Cancer"},{"issue":"6","key":"1061_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen L-L, Chen R, Dean C, Dinger ME, Fitzgerald KA, Gingeras TR, Guttman M, Hirose T, Huarte M, Johnson R, Kanduri C, Kapranov P, Lawrence JB, Lee JT, Wu M (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"1061_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5306\/wjco.v13.i3.209","volume":"13","author":"R Mehrotra","year":"2022","unstructured":"Mehrotra R, Yadav K (2022) Breast cancer in India: Present scenario and the challenges ahead. World J Clin Oncol 13(3):209\u2013218. https:\/\/doi.org\/10.5306\/wjco.v13.i3.209","journal-title":"World J Clin Oncol"},{"key":"1061_CR37","doi-asserted-by":"publisher","first-page":"101653","DOI":"10.1016\/j.tranon.2023.101653","volume":"31","author":"RY Mekky","year":"2023","unstructured":"Mekky RY, Ragab MF, Manie T, Attia AA, Youness RA (2023) MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. Translational Oncol 31:101653. https:\/\/doi.org\/10.1016\/j.tranon.2023.101653","journal-title":"Translational Oncol"},{"issue":"4","key":"1061_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tips.2022.01.008","volume":"43","author":"TR Mercer","year":"2022","unstructured":"Mercer TR, Munro T, Mattick JS (2022) The potential of long noncoding RNA therapies. Trends Pharmacol Sci 43(4):269\u2013280. https:\/\/doi.org\/10.1016\/j.tips.2022.01.008","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1061_CR39","first-page":"418","volume":"46","author":"Y Miao","year":"2016","unstructured":"Miao Y, Fan R, Chen L, Qian H (2016) Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer. Ann Clin Lab Sci 46(4):418\u2013424","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"1061_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ncrna.2020.11.004","volume":"5","author":"P Mondal","year":"2020","unstructured":"Mondal P, Meeran SM (2020) Long non-coding RNAs in breast cancer metastasis. Non-Coding RNA Res 5(4):208\u2013218. https:\/\/doi.org\/10.1016\/j.ncrna.2020.11.004","journal-title":"Non-Coding RNA Res"},{"key":"1061_CR41","doi-asserted-by":"publisher","unstructured":"Mou E, Wang H (2019) LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702. Biosci Rep 39(9). https:\/\/doi.org\/10.1042\/BSR20190489","DOI":"10.1042\/BSR20190489"},{"issue":"6346","key":"1061_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.aai8515","volume":"357","author":"K Naxerova","year":"2017","unstructured":"Naxerova K, Reiter JG, Brachtel E, Lennerz JK, van de Wetering M, Rowan A, Cai T, Clevers H, Swanton C, Nowak MA, Elledge SJ, Jain RK (2017) Origins of lymphatic and distant metastases in human colorectal cancer. Sci (New York N Y) 357(6346):55\u201360. https:\/\/doi.org\/10.1126\/science.aai8515","journal-title":"Sci (New York N Y)"},{"key":"1061_CR43","doi-asserted-by":"publisher","unstructured":"Park EG, Ha H, Lee DH, Kim WR, Lee YJ, Bae WH, Kim H-S (2022) Genomic Analyses of Non-Coding RNAs Overlapping Transposable Elements and Its Implication to Human Diseases. Int J Mol Sci 23(16). https:\/\/doi.org\/10.3390\/ijms23168950","DOI":"10.3390\/ijms23168950"},{"issue":"1","key":"1061_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12860-022-00432-7","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng Y, Huang X, Wang H (2022) lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p. BMC Mol Cell Biology 23(1):34. https:\/\/doi.org\/10.1186\/s12860-022-00432-7","journal-title":"BMC Mol Cell Biology"},{"key":"1061_CR45","doi-asserted-by":"publisher","unstructured":"Peperstraete E, Lecerf C, Collette J, Vennin C, Raby L, V\u00f6lkel P, Angrand P-O, Winter M, Bertucci F, Finetti P, Lagadec C, Meignan S, Bourette RP, Bourhis X, Le, Adriaenssens E (2020) Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions. Cancers 12(7). https:\/\/doi.org\/10.3390\/cancers12071730","DOI":"10.3390\/cancers12071730"},{"issue":"10","key":"1061_CR46","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/tox.23605","volume":"37","author":"Y Qiao","year":"2022","unstructured":"Qiao Y, Wang B, Yan Y, Niu L (2022) Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p\/CDCA3 to inactivate the p53\/p21 signaling pathway. Environ Toxicol 37(10):2398\u20132411. https:\/\/doi.org\/10.1002\/tox.23605","journal-title":"Environ Toxicol"},{"issue":"1","key":"1061_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17(1):47\u201362. https:\/\/doi.org\/10.1038\/nrg.2015.10","journal-title":"Nat Rev Genet"},{"issue":"3","key":"1061_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC (2020) MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol 15(3):261\u2013278. https:\/\/doi.org\/10.1007\/s11523-020-00717-x","journal-title":"Target Oncol"},{"key":"1061_CR49","doi-asserted-by":"publisher","unstructured":"Sebastian-delaCruz M, Gonzalez-Moro I, Olazagoitia-Garmendia A, Castellanos-Rubio A, Santin I (2021) The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization. Non-Coding RNA 7(1). https:\/\/doi.org\/10.3390\/ncrna7010003","DOI":"10.3390\/ncrna7010003"},{"issue":"Pt 1","key":"1061_CR50","doi-asserted-by":"publisher","first-page":"132730","DOI":"10.1016\/j.ijbiomac.2024.132730","volume":"274","author":"P Sengupta","year":"2024","unstructured":"Sengupta P, Roy A, Roy L, Bose D, Halder S, Jana K, Mukherjee G, Chatterjee S (2024) Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer. Int J Biol Macromol 274(Pt 1):132730. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132730","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1061_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-020-00383-y","volume":"7","author":"H Shaath","year":"2021","unstructured":"Shaath H, Vishnubalaji R, Elango R, Khattak S, Alajez NM (2021) Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy. Cell Death Discovery 7(1):23. https:\/\/doi.org\/10.1038\/s41420-020-00383-y","journal-title":"Cell Death Discovery"},{"issue":"2","key":"1061_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1061_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12935-018-0598-8","volume":"18","author":"T Tian","year":"2018","unstructured":"Tian T, Gong Z, Wang M, Hao R, Lin S, Liu K, Guan F, Xu P, Deng Y, Song D, Li N, Wu Y, Dai Z (2018) Identification of long non-coding RNA signatures in triple-negative breast cancer. Cancer Cell Int 18(1):103. https:\/\/doi.org\/10.1186\/s12935-018-0598-8","journal-title":"Cancer Cell Int"},{"key":"1061_CR54","doi-asserted-by":"publisher","first-page":"10569","DOI":"10.2147\/OTT.S229659","volume":"12","author":"Y Tian","year":"2019","unstructured":"Tian Y, Xia S, Ma M, Zuo Y (2019) LINC00096 Promotes the Proliferation and Invasion by Sponging miR-383-5p and Regulating RBM3 Expression in Triple-Negative Breast Cancer. OncoTargets Therapy 12:10569\u201310578. https:\/\/doi.org\/10.2147\/OTT.S229659","journal-title":"OncoTargets Therapy"},{"key":"1061_CR55","doi-asserted-by":"publisher","unstructured":"Tsang JYS, Tse GM (2020) Molecular classification of breast cancer. Adv Anat Pathol 27(1):27\u201335. https:\/\/doi.org\/10.1097\/PAP.0000000000000232","DOI":"10.1097\/PAP.0000000000000232"},{"key":"1061_CR70","doi-asserted-by":"publisher","unstructured":"T\u00e4uber H, H\u00fcttelmaier S, K\u00f6hn M (2019) POLIII-derived non-coding RNAs acting as scaffolds and decoys. J Mol Cell Biol 11(10):880\u2013885. https:\/\/doi.org\/10.1093\/jmcb\/mjz049","DOI":"10.1093\/jmcb\/mjz049"},{"key":"1061_CR56","doi-asserted-by":"publisher","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The Landscape of Targeted Therapies in TNBC. In Cancers (Vol. 12, Issue 4). https:\/\/doi.org\/10.3390\/cancers12040916","DOI":"10.3390\/cancers12040916"},{"key":"1061_CR57","doi-asserted-by":"publisher","unstructured":"Venetis K, Piciotti R, Sajjadi E, Invernizzi M, Morganti S, Criscitiello C, Fusco N (2021) Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management. Cells 10(6). https:\/\/doi.org\/10.3390\/cells10061377","DOI":"10.3390\/cells10061377"},{"issue":"November","key":"1061_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.526850","volume":"10","author":"SR Volovat","year":"2020","unstructured":"Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I (2020) MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol 10(November):1\u201315. https:\/\/doi.org\/10.3389\/fonc.2020.526850","journal-title":"Front Oncol"},{"key":"1061_CR59","doi-asserted-by":"publisher","first-page":"102076","DOI":"10.1016\/j.tranon.2024.102076","volume":"49","author":"X Wang","year":"2024","unstructured":"Wang X, Jian Q, Zhang Z, Gu J, Wang X, Wang Y (2024) Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN\/Hippo\/YAP axis. Translational Oncol 49:102076. https:\/\/doi.org\/10.1016\/j.tranon.2024.102076","journal-title":"Translational Oncol"},{"issue":"2","key":"1061_CR60","doi-asserted-by":"publisher","first-page":"112331","DOI":"10.1016\/j.yexcr.2020.112331","volume":"396","author":"G Wu","year":"2020","unstructured":"Wu G, Zhou H, Li D, Zhi Y, Liu Y, Li J, Wang F (2020) LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis. Exp Cell Res 396(2):112331. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112331","journal-title":"Exp Cell Res"},{"key":"1061_CR71","doi-asserted-by":"publisher","unstructured":"Xiaohua L, Lili H, Lei Y, Shuai Z (2020) LncRNA XIST interacts with miR-454 to inhibit cells proliferation epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer. J Biosci 45(1). https:\/\/doi.org\/10.1007\/s12038-020-9999-7","DOI":"10.1007\/s12038-020-9999-7"},{"issue":"6","key":"1061_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5306\/wjco.v6.i6.252","volume":"6","author":"BS Yadav","year":"2015","unstructured":"Yadav BS, Chanana P, Jhamb S (2015) Biomarkers in triple negative breast cancer: A review. World J Clin Oncol 6(6):252\u2013263. https:\/\/doi.org\/10.5306\/wjco.v6.i6.252","journal-title":"World J Clin Oncol"},{"issue":"3","key":"1061_CR62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.bj.2021.05.002","volume":"45","author":"X Yang","year":"2022","unstructured":"Yang X, Yang Y, Qian X, Xu X, Lv P (2022) Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression. Biomedical J 45(3):512\u2013521. https:\/\/doi.org\/10.1016\/j.bj.2021.05.002","journal-title":"Biomedical J"},{"issue":"3","key":"1061_CR64","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1096\/fj.201901384RR","volume":"34","author":"J Yin","year":"2020","unstructured":"Yin J, Tu G, Peng M, Zeng H, Wan X, Qiao Y, Qin Y, Liu M, Luo H (2020) GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 34(3):4557\u20134572. https:\/\/doi.org\/10.1096\/fj.201901384RR","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"1","key":"1061_CR63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12943-024-02131-7","volume":"23","author":"Q Yi","year":"2024","unstructured":"Yi Q, Feng J, Lan W, shi H, Sun W, Sun W (2024) CircRNA and lncRNA-encoded peptide in diseases, an update review. Mol Cancer 23(1):214. https:\/\/doi.org\/10.1186\/s12943-024-02131-7","journal-title":"Mol Cancer"},{"issue":"12","key":"1061_CR65","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.21873\/anticanres.16750","volume":"43","author":"H Yu","year":"2023","unstructured":"Yu H, Wu Y, Huang J, Li S (2023) lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer. Anticancer Res 43(12):5475\u20135484. https:\/\/doi.org\/10.21873\/anticanres.16750","journal-title":"Anticancer Res"},{"issue":"10","key":"1061_CR66","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/15384101.2022.2040283","volume":"21","author":"J Zhang","year":"2022","unstructured":"Zhang J, Du C, Zhang L, Wang Y, Zhang Y, Li J (2022a) LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1\u03b1 through the NF90\/NF45 complex. Cell Cycle (Georgetown Tex) 21(10):1034\u20131047. https:\/\/doi.org\/10.1080\/15384101.2022.2040283","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"1061_CR67","doi-asserted-by":"publisher","unstructured":"Zhang P, Wu W, Chen Q, Chen M (2019) Non-Coding RNAs and their Integrated Networks. J Integr Bioinform 16(3). https:\/\/doi.org\/10.1515\/jib-2019-0027","DOI":"10.1515\/jib-2019-0027"},{"issue":"1","key":"1061_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00018-021-04120-1","volume":"79","author":"W Zhang","year":"2022","unstructured":"Zhang W, Yang S, Chen D, Yuwen D, Zhang J, Wei X, Han X, Guan X (2022b) SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K\/Akt signaling. Cell Mol Life Sci 79(1):59. https:\/\/doi.org\/10.1007\/s00018-021-04120-1","journal-title":"Cell Mol Life Sci"},{"issue":"42","key":"1061_CR69","doi-asserted-by":"publisher","first-page":"e2407493","DOI":"10.1002\/advs.202407493","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wei S, Chen Z, Xu R, Li S-R, You L, Wu R, Zhang Y, Liao J-Y, Xu X, Song E, Luo M-L (2024) LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer. Adv Sci (Weinheim Baden-Wurttemberg Germany) 11(42):e2407493. https:\/\/doi.org\/10.1002\/advs.202407493","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"}],"updated-by":[{"DOI":"10.1007\/s13353-026-01068-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000}}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01061-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-026-01061-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01061-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:13:40Z","timestamp":1788243220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-026-01061-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s13353-026-01061-y","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"The original online version of this article was revised: In the original version of the manuscript, the family name of the fourth author was incorrectly given as \u201cAgrawal.\u201d Her correct surname is \u201cAdnani.\u201d This should be corrected to Nishita Adnani instead of Nishita Agarwal. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13353-026-01068-5","URL":"https:\/\/doi.org\/10.1007\/s13353-026-01068-5","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}